| USA / Grants |  previous grant / next grant  |
Contact: Erwin Böttinger, M.D. , Director of the Charles Bronfman
Institute for Personalized Medicine
phone: 212-241-0800
email: erwin.bottinger@mssm.edu
Press Release: Data From Mount Sinai Biobank Provides Critical Insight Into Personalized Medicine, May 4, 2011
Press Release: Mount Sinai Charles R. Bronfman Institute for Personalized Medicine Biobank Enrolls 14,000, February 5, 2011
Press Release: Personalized Medicine Arrives At Mount Sinai Medical Center, October 15, 2010
Newsletter: Gift Will Create New Institute for Personalized Medicine, Inside Mount Sinai, April 16-22, 2007
Article: Profiles in Family Philanthropy Family Giving News, May /June 2007
Podcast:Interview with Erwin Bottinger, M.D., Winter 2007
The Charles R. Bronfman Institute of Personalized Medicine
The Charles R. Bronfman Institute for Personalized Medicine (IPM) at The Mount Sinai Medical Center in Manhattan will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a person's genetic make-up to customize strategies for the detection, treatment, and prevention of disease. The $12.5 million ACBP gift will be used to fund an institution-wide Biobank at Mount Sinai and to establish the Translational Biomedical Informatics Center, two areas of focus for the Institute for Personalized Medicine, seed-funding Mount Sinai's overall $30 million personalized medicine initiative. The grant will be paid out over a period of 10 years.
The Charles R. Bronfman Institute for Personalized Medicine (IPM) at The Mount Sinai Medical Center in Manhattan will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a person's genetic make-up to customize strategies for the detection, treatment, and prevention of disease. The $12.5 million ACBP gift will be used to fund an institution-wide Biobank at Mount Sinai and to establish the Translational Biomedical Informatics Center, two areas of focus for the Institute for Personalized Medicine, seed-funding Mount Sinai's overall $30 million personalized medicine initiative. The grant will be paid out over a period of 10 years.
Landmark discovery efforts in genome and information sciences have provided life scientists with powerful tools for gaining a deeper understanding of the role genes and environment play in health and disease. Personalized medicine transforms the traditional "one-size-fits-all" model of medicine by incorporating each individual's unique genomic make-up and environmental exposure to better manage their disease predispositions or diseases. The Institute examines how this new model of genome-informed personalized healthcare may be translated in clinical settings to advance the practice, delivery and economics of health care.
